Diabetes 17 Points A clinical trial was performed on 465 patients, aged 10-17, who suffered from Type 2 Diabetes These patients were randomly assigned to one of two groups Group 1 met) was treated with a drug called metformin Group 2 frosi) was treated with a drug called rosiglitazone At the end of the experiment, there were two possible outcomes. Outcome 1 is that the patient no longer needed to use insulin Outcome 2 is that the patient still needed to use insulin 232 patients were assigned to the met treatment, and 112 of them no longer needed insulin after the treatment 233 patients were assigned to the ros treatment, and 143 of them no longer needed insulin after the treatment,